How to wean someone off Xanax (alprazolam) with a non-benzodiazepine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Weaning Patients Off Alprazolam Using Non-Benzodiazepine Alternatives

For patients requiring discontinuation of alprazolam (Xanax), the most effective approach is to substitute with a non-benzodiazepine medication such as buspirone, starting at 5 mg twice daily and gradually increasing to 20 mg three times daily while simultaneously tapering the alprazolam dose by 10-20% every 1-3 days. 1

Assessment Phase

Before initiating the weaning process, determine:

  • Duration of alprazolam use
  • Total daily dose
  • Presence of comorbid conditions (anxiety, depression, insomnia)
  • History of previous withdrawal attempts

Non-Benzodiazepine Substitution Options

First-Line Options:

  1. Buspirone

    • Start 2 weeks before completing alprazolam taper
    • Initial dose: 5 mg twice daily
    • Titrate up to maximum 20 mg three times daily as needed
    • Takes 2-4 weeks to become fully effective
    • Best for mild to moderate anxiety symptoms 1
  2. SSRIs for comorbid anxiety/depression

    • Fluoxetine, paroxetine, sertraline, or citalopram
    • Particularly useful when anxiety co-occurs with depression
    • Begin SSRI at least 2 weeks before completing alprazolam taper 1
  3. Carbamazepine as adjunctive therapy

    • Dosage: 200-800 mg/day
    • Has shown promise in helping patients remain benzodiazepine-free after taper
    • Most beneficial for patients on higher doses (≥20 mg/day diazepam equivalent) 2

For Sleep Disturbances During Withdrawal:

  • Mirtazapine: 7.5 mg at bedtime, can increase to 30 mg as needed
  • Trazodone: Low doses for sleep and anxiety during withdrawal 1

Alprazolam Tapering Protocol

  1. For patients on alprazolam >14 days:

    • Consider substituting with chlordiazepoxide using a 50:1 ratio (50 mg chlordiazepoxide = 1 mg alprazolam)
    • Begin non-benzodiazepine medication (buspirone or SSRI) concurrently
    • Taper chlordiazepoxide by 10% every 1-3 days 1, 3
  2. For patients on alprazolam 7-14 days:

    • Use a faster taper schedule of 10-20% reduction every 1-2 days
    • Monitor closely for withdrawal symptoms 1
  3. For patients on alprazolam <7 days:

    • May discontinue quickly with minimal risk of significant withdrawal 1

Monitoring During Tapering

  • Assess for withdrawal symptoms at each dose reduction
  • Common withdrawal symptoms include:
    • Anxiety, tremor, insomnia, nausea, sweating, tachycardia, headache
    • Seizures (rare but serious)
  • If withdrawal symptoms emerge:
    • Temporarily hold at current dose
    • Consider slowing the taper rate to 5-10% reductions
    • Increase adjunctive non-benzodiazepine medication 4

Common Pitfalls to Avoid

  1. Abrupt discontinuation - can lead to severe withdrawal including seizures
  2. Substituting with another short-acting benzodiazepine - perpetuates dependence
  3. Tapering too quickly - aim for withdrawal in <6 months to prevent the process from becoming the focus of the patient's existence 5
  4. Neglecting reassessment after interventions - crucial to evaluate effectiveness 6
  5. Ignoring psychological support - cognitive-behavioral therapy can be particularly effective in preventing relapse 5

Special Considerations

  • Elderly patients may require a more gradual taper (5% reduction) and lower substitution ratios (25:1 for chlordiazepoxide) 3
  • Long-term users (>8 months) may benefit from inpatient monitoring during initial substitution 7
  • Patients with comorbid substance use disorders require closer monitoring and specialized addiction services

By following this structured approach with non-benzodiazepine substitution and gradual tapering, most patients can successfully discontinue alprazolam with minimal withdrawal symptoms and improved long-term outcomes.

References

Guideline

Alprazolam Discontinuation Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Detoxification from benzodiazepines: schedules and strategies.

Journal of substance abuse treatment, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.